| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |